Coca-Cola European Partners PLC (CCEP)
Madrid Exchange · Spain · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 100.60 |
|---|---|
| 52-week range | 72.60 – 102.00 |
| Return, 1 month / 3 months | +12.8% / +10.2% |
| Return, 1 year / 3 years | +29.7% / +104.7% |
| Trend | Uptrend |
| RSI (14) | 84 |
| Volatility (1 year) | 22.6% |
| Worst drawdown (1 year) | -17.1% |
| Average daily value traded | 0.10M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Coca-Cola European Partners bottles, sells and distributes Coca-Cola branded drinks and other beverages across Western Europe. Its range covers sparkling soft drinks, waters, juices, sports drinks and ready-to-drink teas, which it produces at local bottling plants and delivers to retailers, restaurants, hotels and other outlets. The company serves consumers and trade customers in markets such as Spain, France, Germany, the United Kingdom, Belgium and the Netherlands, and it is headquartered in Uxbridge, near London.
Coca-Cola European Partners PLC trades under the code CCEP on the Madrid Exchange in Spain, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Coca-Cola European Partners PLC (CCEP) trades on the Madrid Exchange in Spain. It last closed at EUR 100.60 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 13 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.7% and over the last three months it rose 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.3% | ||
| From 52-week high | 0.0% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.2% | ||
| 6-month return | 23.5% | ||
| 12-month return, skipping the last month | 15.0% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.1% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.10M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | +12.8% |
| 3 months | +10.2% |
| 6 months | +23.5% |
| 1 year | +29.7% |
| 3 years | +104.7% |
| 5 years | +156.5% |
Signals
| 50-day / 200-day average | 92.40 / 86.47 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | GBP 0.8255 |
| 13 Nov 2025 | GBP 1.2500 |
| 15 May 2025 | GBP 0.7900 |
| 14 Nov 2024 | GBP 1.2670 |
| 9 May 2024 | GBP 0.7331 |
| 16 Nov 2023 | GBP 1.1308 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.